ResMed To Add To Software Offerings With $750M MatrixCare Acquisition
Xconomy
NOVEMBER 5, 2018
The purchase price is 25 times MatrixCare’s pro forma 2018 earnings of about $30 million (without taking into account interest, taxes, depreciation or amortization) on anticipated net revenue of about $122 million. San Diego’s ResMed (NYSE: ticker[[RMD]]) announced its intention to buy the privately held tech company on Monday.
Let's personalize your content